Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide
J. Clin. Invest. Nathan R. Martinez, et al. 111:1365
doi:10.1172/JCI17166 [Go to this article.]

Problems with a PDF?